The immune system for the built world.
Drug-resistant bacteria will soon kill more people every year than cancer. We build the closed autonomous loop that detects, contains, and neutralizes pathogens — before a human ever knows they're there.
- Detect
- Contain
- Neutralize
- CLOSED · 24/7
deaths a year by 2050 — overtaking cancer as the world's leading killer
The antibiotic era is ending. Left unchecked, drug-resistant infections are on track to kill 10 million people a year at a cumulative cost of $100 trillion.
A scraped knee. A routine surgery. A simple fever. Each becomes potentially fatal again.
In the sealed, shared air of a forward base, a ship, or a field hospital, one resistant pathogen can take an entire team off the board faster than any bullet.
- 1.27MDeaths already caused directly, each year (2019)
- ~40MProjected AMR deaths over the next 25 years
- 35K+U.S. deaths a year, and climbing
Sources: O'Neill AMR Review · Lancet GRAM, 2024
By the time a human knows, it has already spread.
- 01 · Detect
Days, not minutes
Identifying a pathogen means a swab, a courier, a lab — a 2–5 day round trip while it multiplies, unseen.
- 02 · Contain
A memo and a mop
Response is manual: a nurse notices, a form is filed, a crew is dispatched. The air keeps circulating the whole time.
- 03 · Neutralize
Needs a building
The autoclave that could kill it wants water, steam, power, and a clean room — none of which exist in the field.
Three broken steps · Three human bottlenecks · The loop never closes
Close the loop. Take the human out of it.
One autonomous system that senses, isolates, and sterilizes a threat in a single continuous cycle — turning every high-stakes building into its own immune system.
- 01 · Detect
Sentinel
Autonomous Air SensingReads the air continuously and names the pathogen — and patient zero — in minutes.
- 02 · Contain
Chrysalis
Command & ResponseCloses HVAC, isolates the zone, quarantines automatically — before anyone is told.
- 03 · Neutralize
FOCUS
Sterilization — Shipping NowDelivers a guaranteed UV-C kill-dose by geometry. Real hardware, today.
Kill-dose in 90 seconds.
FOCUS is the neutralize stage — real, working hardware today. A sealed reflective chamber puts a guaranteed UV-C kill-dose on every surface at once: dry, cold, chemical-free. The autoclave needs a building; FOCUS needs a wall outlet — and it's the revenue that funds the rest of the loop.
- 90sKill-dose cycle
- $0Water · steam · consumables
- 99%*Kill · early bench testing
- ~$30KTarget unit price
*Early bench testing · not yet third-party validated.
The two stages that make it autonomous.
Sentinel
- Samples a room's air 24/7 — no technician, no swab, no lab trip.
- Flags a biological signature in minutes, not days.
- Pinpoints the individual patient zero before it spreads.
Chrysalis
- Closes HVAC and isolates the affected air zone instantly.
- Fires UV-C decontamination and quarantines automatically.
- Alerts the right people — the loop acts before a human decides.
Built on the reflective-chamber + UV-C platform proven by FOCUS · funded by FOCUS revenue
An ellipsoid has two foci. Any ray from one focus reflects off the wall and converges at the other — always. Put a UV-C source at one focus and the target at the other, and every face of every surface receives a kill-dose at once.
The geometry can't be copied with a firmware update — and the loop compounds it. Physics is the wall; every deployment's detection data is the flywheel.
- Patent portfolio
- 2 provisional + 1 utility + 1 PCT, filed
- Mechanism
- Shadow-free dosing, guaranteed by mathematics
- Maturity
- TRL 3–4 · working prototype
Enter at the sharpest edge. Expand to every building.
Global sterilization & infection-control equipment — the front line against a $100T resistance crisis.
Autonomous detect-and-sterilize for high-stakes facilities — bases, ships, hospitals, transit.
~30,000 U.S. military medics × $5K unit — the entry wedge, reachable with no FDA gate.
Beachhead → hospitals & ships → every high-stakes building
$35K. One prototype. Zero full-time employees. Here's the mile we've already run —
- $35K
In grants and angel funding — the entire budget to date.
- 4
Patents filed — two provisional, one utility, one PCT international.
- 8
Letters of interest — 3 rural clinics (India), 5 Utah pain clinics; plus verbal LOIs from Utah eye clinics.
- 3
Federal briefings — USAF, US SOCOM, Defense Health Agency; USAF lab eval underway.
Imagine the next mile with real capital
LTC Elizabeth Powell, MD
USAF · SOST2× DoD grant recipient. Called FOCUS “phenomenal — something people need,” and is facilitating its Air Force lab evaluation.
Luke Sciulli
SFC(R) · Green BeretDecorated, combat-wounded, with frontline medical experience across Africa, Ukraine, and Afghanistan. Advises the Pentagon, Congress, and military partners on advanced medical tech and unmanned systems.
Michael Hetzler
SGM · JSOC25+ years in mobile surgical units, enemy-territory care, and field sterilization. NATO medical-education leader and University College Cork lecturer.
Mitchell Goff, MD
Army-trained · OphthalmologyTrained at the Medical College of Wisconsin; specialized in vitreoretinal surgery through fellowship in San Francisco.
Krishnam Goel
Founder & CEO · Airavata Bioengineering“Phenomenal — something people need.”
— USAF Special Operations Surgical Team surgeon, on FOCUS
My grandfather died of hospital-acquired tuberculosis. My aunt, of hospital-acquired meningitis. Neither died of what brought them in — they died of the infection no one caught in time.
Three patents, eleven papers, and a prior raise — at 19, on $35K. I walked away from $600K in fellowships to hold out for investors who fit this thesis, and I will go through every wall to build it.
- 19Years old
- 3Patents filed
- 11Research publications
- $600KTurned down in fellowships
- Co-founder, Cyris — raised $100K at $2M from Convoi Ventures
- ISEF Finalist · Eccles Scholar — 1 of 20 from 6,700+ (full ride)
- Researcher — Huntsman Cancer Institute & Stanford
Krishnam Goel · Salt Lake City
Finding early believers.
We're raising a $500K round from early believers — the operators who've built hardware from nothing. It funds early pilot prototypes, the FDA pathway, ISO testing, and SBIR submissions.
- Round
- $500K
- Ticket
- $50K – $500K
- Funds
- Early pilot prototypes · FDA pathway · ISO testing · SBIRs
- Looking for
- Hardware builders who invest early and back the category